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ABSTRACT
Chemically engineered small molecules targeting
specific genomic sequences play an important role
in drug development research. Pyrrole-imidazole
polyamides (PIPs) are a group of molecules that can
bind to the DNA minor-groove and can be engineered
to target specific sequences. Their biological effects
rely primarily on their selective DNA binding. How-
ever, the binding mechanism of PIPs at the chroma-
tinized genome level is poorly understood. Herein,
we report a method using high-throughput sequenc-
ing to identify the DNA-alkylating sites of PIP-indole-
seco-CBI conjugates. High-throughput sequencing
analysis of conjugate 2 showed highly similar DNA-
alkylating sites on synthetic oligos (histone-free
DNA) and on human genomes (chromatinized DNA
context). To our knowledge, this is the first report
identifying alkylation sites across genomic DNA by
alkylating PIP conjugates using high-throughput se-
quencing.
INTRODUCTION
N-Methylpyrrole (P)––N-methylimidazole (I) polyamides
(PIPs) are a class of programmable minor-groove binders
that follow a canonical DNA recognition rule. The recogni-
tion rules are that an antiparallel arrangement of P oppo-
site I (P-I) recognizes a C-G base pair; I-P recognizes a G-
C base pair and P-P recognizes T-A or A-T base pairs (1).
Several studies have investigated the binding specificity of
these programmable PIPs (2–7). However, there is a bias to-
ward PIPs binding chromatinized DNA. PIPs have the abil-
ity to penetrate the cell membrane and show an excellent
DNA-binding efficiency, even in nanomolar concentrations
(8), thus hindering the binding of transcription factors to
their respective DNA sequences.
The normal transcriptional machinery sometimes be-
comes dysfunctional because of alteration of DNA bases
causing variation in gene expression and development of
disease. Such fluctuations in gene regulation, largely dic-
tated by modifications such as DNA alkylation and methy-
lation, are caused by various factors in day-to-day life
(9,10). DNAdamage induced by alkylating agents canmod-
ify the genetic code, resulting in faulty protein synthesis
(9,11) that can cause abrupt cell-cycle arrest or apoptosis
(12). This makes alkylating agents attractive as antitumor
drugs. To date, many DNA-alkylating agents have been re-
ported to exhibit anticancer activity toward a variety of
leukemias and solid tumors (13). One of the major disad-
vantages of these agents is their non-selective DNA alky-
lation. Driving the alkylating agents toward tumor-specific
target sequences in the human genome is a promising ap-
proach to advancing their efficacy as anticancer agents. Col-
lectively, we developed various sequence-specific alkylating
agents by coupling sequence-specific PIPs with alkylating
moieties (14). Among the coupling linkers, the indole linker
extends to two bases and its N-terminal sequence selectiv-
ity is achieved by the hydrogen bond of the amide group of
indole with O2 of C or T, or with N3 of adenine (A) (15,16).
Conjugating the alkylating moiety seco-CBI to a PIP can
produce a covalent adduct with N3 of A within a predeter-
mined sequence (Figure 1A and C). A PIP-indole-seco-CBI
conjugate with unique sequence recognition was tested for
antitumor activity by selective silencing of tumor-inducing
genes (17). In this study, we have synthesized two PIP-
indole-seco-CBI conjugates (1 with a symmetrical binding
site of 5′-WGGCCA-3′ and 2 with asymmetrical binding
site 5′-WGGWCA-3′ (Scheme 1)) to investigate their DNA-
alkylating sites.
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Figure 1. PIP conjugate-binding mode and Bind-n-Seq. (A) Recognition of DNA minor groove by PIP-indole-seco-CBI conjugates. (B) Workflow of
Bind-n-Seq analysis with PIP-indole-seco-CBI conjugate. (C) PCR amplification-based depurinated strand retrieval and chemical reaction of DNA N3
alkylation by seco-CBI through the formation of CBI and heat treatment.
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Previous studies have employed high-resolution denatur-
ing polyacrylamide gel electrophoresis to test the sequence-
specific DNA-alkylating efficiency of PIP-seco-CBI conju-
gates on pre-determined 200–300 bp template sequences.
Under high-temperature conditions, alkylated sequences
at the PIP-binding sites are cleaved, generating patterns
of DNA fragments, which can be analyzed further (14–
16). However, the selective DNA-alkylating ability of PIP-
seco-CBI conjugates in a broad genome space using high-
throughput sequencing has not yet been explored. Here, we
describe the experimental design and data analysis methods
to address this investigation.
Although PIP conjugates have many predicted binding
sites across the human genome, only a small number of
these binding sites play a significant role in gene regula-
tion. This phenomenon is clearly observed in our previ-
ous report, where the whole genome expression analysis
of a library of SAHA-PIP conjugates showed that indi-
vidual compounds can trigger a distinctive set of genes in
human dermal fibroblast (HDF) cells (18). The complex
organization of chromatin packaging in the nucleus may
be a critical factor for the PIP-binding preferences along
the genome (19–21). A recent report by the Ansari group
(22) has initiated the preliminary effort to map the PIP-
binding sites in the human genome by developing an ap-
proach called ‘crosslinking of small molecules for isolation
of chromatin’ or COSMIC, thereby directing the evolution
in PIP design strategy for effectively targeted gene regula-
tion. Data provided by ChIP-seq regarding the genome-
wide mapping of key transcription factors and regulatory
element-binding sites are helpful in the derivation of tran-
scriptional regulation models that govern normal and dis-
eased cell states (23,24). At this juncture, we have em-
ployed cost-efficient semiconductor-sequencing technology
to study the affinity purification-based high-throughput se-
quencing of PIP-indole-seco-CBI conjugate-enriched hu-
man genomic regions. The present study will enable us to
map the DNA-binding of small molecule DNA-alkylating
sites all along the chromatin-packed genome utilizing high-
throughput sequencing, which may provide a more detailed
understanding of the mechanism of gene regulation by PIP
conjugates.
MATERIALS AND METHODS
Synthesis of biotin-conjugated alkylating polyamide conju-
gates
Reagents and solvents were purchased from standard
providers and used without further refinement. The EZ-
Link NHS-PEG12-Biotin was obtained from Thermo Sci-
entific, USA (No. 21312). Analytical High Performance
Liquid Chromatography (HPLC) was performed using a
COSMOSIL 5C18-MS-II reversed phase column (4.6× 150
mm, Nacalai Tesque) in 0.1% Trifluoroacetic acid (TFA)
in water with CH3CN as eluent at 1.0 ml/min, and a lin-
ear gradient elution of 0−100% CH3CN over 20 or 40 min
with detection at 254 nm. The HPLC purification was per-
formed with a COSMOSIL 5C18-MS-II reversed phase col-
umn (10 × 150 mm, Nacalai Tesque) in 0.1% TFA in water
with CH3CN as the eluent. The final products were ana-
lyzed by ESI-TOF-MS (Bruker). The complete PIP synthe-
sis procedure is provided in Supplementary Data.
Bind-n-Seq experiment and high-throughput sequencing
Bind-n-Seq experiments and high-throughput sequencing
were performed based on our previous report (25). Broadly,
(i) Synthesis of biotinylated alkylating PIPs and
PIP-Conjugate 5 (a PIP conjugate where the
alkylating CBI moiety was substituted with 3-
dimethylaminopropylamine (Dp), synthesis details
are given in Supplementary Data) (26), and a separate
set of oligonucleotides with a 10- and 21-mer ran-
domized region and Ion torrent adapters. (Oligomer
designs and details are given in Supplementary Data)
Oligonucleotides were duplexed by primer extension.
Biotin conjugated alkylating PIPs and PIP-Conjugate
5 were allowed to bind and alkylate with their specific
binding region of duplex randomized oligonucleotides
separately at room temperature. Control experi-
ments were performed without PIP-indole-seco-CBI
conjugates/PIP-Conjugate 5, the data obtained were
used for the normalization to acquire enrichment
data. Biotin–streptavidin affinity-based purification
was used to enrich the alkylating PIP attached DNA
(washing steps were doubled for the PIP-indole-
seco-CBI conjugates compared with the previously
reported Bind-n-Seq to remove PIP simple binding).
(ii) Enriched DNA was subjected to polymerase chain re-
action (PCR) to recover the alkylated DNA strand us-
ing sequencing library adapter-specific primers. The
purified sequencing libraries were quantified using
a BioAnalyzer with an Agilent DNA High Sensi-
tivity BioAnalyzer kit, Agilent technologies, USA.
Sufficient sequencing libraries with various barcodes
were pooled for template preparation (Ion Personal
Genome Machine (PGM) template OT2 200 kit) in an
Ion OneTouch 2 system. The emulsion PCR amplified
libraries were further enriched with Ion OneTouch ES.
The enriched libraries were sequenced following the
manufacturer’s instructions with Ion PGM sequencer
(Ion PGM sequencing 200 kit v2 and 318 chip V2 (Life
Technologies, USA).
(iii) The sequenced readswere analyzed for a primarymotif
calling based on our previous reports (25–29).
Affinity purification-based high-throughput sequencing of hu-
man genomic regions enriched with PIP-indole-seco-CBI
conjugate 2
Human fibroblast BJ from neonatal foreskin (ATCC,
USA), were maintained in 10% fetal bovine serum (FBS)
(FBS, Japan Serum) supplemented with Dulbecco’s modi-
fied eagle medium (DMEM, Nacalai Tesque, Japan), 10%
HyClone FBS, non-essential amino acids, 100 U/ml peni-
cillin, 100 g/ml streptomycin and grown to 75–80% con-
fluency in a humidified atmosphere of 5%CO2 at 37◦C. Nu-
clei were isolated for alkylating PIP treatment (30–33). In
brief, 2× 106 P6 cells were washed with phosphate buffered
saline (PBS) and isolated by 3 min trypsinization. The iso-
lated cells were again washed 2×with ice-cold PBS. The cell
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pellet was suspended in 5 ml of ice-cold NP-40 lysis buffer
(10 mM Tris–HCl (pH 7.4), 10 mM NaCl, 3 mM MgCl2,
0.5% Nonidet P-40, 0.15 mM spermine, 0.5 mM spermi-
dine and 0.1× protease inhibitor cocktail) and incubated
on ice for 5 min. The nuclei were pelleted by centrifuga-
tion at 300 g for 10 min. The pellet of nuclei was carefully
resuspended in modified binding buffer (22) (10 mM Tris–
Cl (pH 8.0), 5 mM MgCl2, 1 mM DTT, 0.3 M KCl, 0.3×
protease inhibitor cocktail and 10% glycerol). The nuclei
were incubated with 400 nMof 2 (dissolved inDimethyl sul-
foxide (DMSO), 0.1% final concentration) at 4◦C for 16 h.
Control experiments were performed without PIP-indole-
seco-CBI conjugates and with a 0.1% final concentration of
DMSO. We used the PIP concentrations from the previous
report (22) that were consistent with the PIP quantity mea-
sured in the nuclei of treated cells (34). PIP-containing nu-
clei were washed with micrococcal nuclease (MNase) buffer
(10 mMTris–HCl (pH 7.4), 15 mMNaCl, 60 mMKCl, 0.15
mM spermine, 0.5 mM spermidine and 0.1× protease in-
hibitor cocktail) (30). Cell nuclei suspension was digested
with MNase (TaKaRa, Japan) for 30 min at 37◦C to ob-
tain mononucleosomes in optimized reaction conditions.
The reactions contained MNase buffer, MNase (0.2 l of
MNase (20 Units/l) for nucleus extracted from 2 × 106
cells), RNaseA and protease inhibitor cocktail. After diges-
tion, the histone protein was removed by proteinaseK treat-
ment. After MNase digestion and proteinase K treatment
the suspension wasmixed with an equal volume of modified
COSMIC buffer (20 mM Tris–Cl (pH 8.1), 2 mM ethylene-
diaminetetraacetic acid (EDTA), 150 mMNaCl, 0.1× pro-
tease inhibitor cocktail, 1% Triton-X100 and 0.1% sodium
dodecyl sulphate (SDS)) (22). Ten percent of the sample was
saved as inputDNA. The assessment of the size distribution
of DNA samples showed about 100–180 bp fragment distri-
bution.
Preparation of magnetic beads. After removing the sus-
pension solution from streptavidin-coated magnetic beads
(Dynabeads MyOne C1, Life Technologies, USA). They
were washed with 2×modified COSMIC buffers and resus-
pended in the same buffer. Resuspended streptavidin-coated
magnetic beads (0.5 mg) were incubated with samples for
16 h at 4◦C. After the incubation period, bound and un-
bound DNA samples were separated using affinity purifi-
cation. Briefly, samples were washed 5 min once with 0.5 ml
of washing buffer 1 (10mMTris–Cl (pH 8.0), 1 mMEDTA,
3% SDS), once with altered washing buffer 2 (10 mM Tris–
Cl (pH 8.0), 250 mM LiCl, 1 mM EDTA, 0.5% NP40), 2×
with altered washing buffer 3 (10 mM Tris–Cl (pH 7.5), 1
mM EDTA, 0.1% NP-40) and 3× with TE. The samples
were then resuspended in elution buffer (10 mM Tris–HCl
(pH 7.6), 0.4mMEDTAand 100mMKOH) (22) andDNA
was eluted frommagnetic beads after heating at 90◦C for 30
min. The remaining DNA with the beads were eluted using
elution buffer 2 (2% SDS, 100 mMNaHCO3 and 3 mM bi-
otin) with heating to 65◦C for 8–12 h. The detached samples
were purified with a QIAquick PCR purification Kit (Qia-
gen, CA, USA) and quantified.
Polyamide-based affinity purification sequencing li-
braries were prepared using standard Ion Xpress Plus
gDNA Fragment Library Preparation reagents and pro-
tocols (Life technologies, USA). Sequencing adapter lig-
ated enriched DNA was subjected to a PCR to recover
the alkylated DNA strand using sequencing library adapter
specific primers and purified. The purified libraries were
subjected to quality and quantity checks with an Agilent
DNA High sensitivity BioAnalyzer kit (Agilent technolo-
gies, USA). The qualified libraries were used for high-
throughput sequencing. The sequencing was performed,
startingwith template preparation using Ion PGMtemplate
OT2 200 v2 kit and an Ion PI template OT2 200 kit using
an Ion OneTouch 2 system. The templates were then en-
riched using Ion OneTouch ES. The enriched libraries were
sequenced with 260–300 flow of a single read performed
with an Ion PGM sequencer using an Ion PGM sequenc-
ing 200 kit v2/318 v2 chip and an Ion Proton Sequencer
using an Ion PI Sequencing 200 kit v3/Ion PI chip follow-
ing the manufacturer’s guidelines and we produced 25–30
million post filtered reads per library. The data were han-
dled by employing standard program packages in the Ion
torrent suite. A Torrent Mapping Alignment Program ver-
sion 4.4.2 (TMAP) was used for aligning reads (mean read
length 121 bp), ChIP-seq peaks were called using MACS
version 1.4.2 (35) with the default parameters and aP-value
< 0.001 (cutoff<10–2) (In total, 721 617 peaks were called).
Enriched peak and PIP-indole-seco-CBI conjugate binding
site annotations weremade usingHomer (36). To determine
the high-affinity DNA-alkylating sites (motif) of 2 over
the control sequence reads, a randomly sampled 10–15%
of the uniquely mapped reads for each setting were used.
The random sampling was performed using a Perl script
(http://meme-suite.org/doc/fasta-subsample.html). We fol-
lowed our previous analysis pipeline for motif calling (25–
29).
We evaluated the genome-wide enrichment signature of
2 by calculating the cross-correlation of MACS peaks
with the identified binding sites (DNA-alkylating motif).
The peaks containing identified binding sites were consid-
ered as significant enrichment regions (total of 355 882
peaks). Analysis pipelines agplus (37), PositionWeightMa-
trix model generation and evaluation-PWMScan (http://
ccg.vital-it.ch/pwmscan) (38,39), ChIP-Cor Analysis Mod-
ule (http://ccg.vital-it.ch/chipseq/chip cor.php) and various
platforms of the Signal Search Analysis Server (http://ccg.
vital-it.ch/ssa) were used to evaluate the spatial precision of
2 enrichment data.
Validating PIP-indole-seco-CBI conjugate 2 bound and en-
riched region in the human genome
Human fibroblast BJ from neonatal foreskin and SKBR3
(breast adenocarcinoma, human) cell lines were purchased
fromATCC. Fibroblast cells were grown inDMEMsupple-
mented with 10%HyClone FBS, non essential amino acids,
100U/ml penicillin, 100g/ml streptomycin, at 37◦C in 5%
CO2. SKBR3 cells were grown in ATCC-formulated Mc-
Coy’s 5a modified medium complemented with 10% FBS
and were maintained under an atmosphere of 5% CO2 at
37◦C.
The effect of alkylating PIP 2 on the expression ofERBB2
mRNA was determined in both fibroblast and SKBR3 cell
lines using real-time PCR. BJ skin fibroblast cells were
seeded at a density of 5 × 104 cells/well of a 6-well plate
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Scheme 1. Chemical structures and representation of PIP-indole-seco-CBI conjugate. (A) 1 (Ac-I-I-P-P-(R)NH-PEG12-Biotin -I-I-Indole-seco-CBI). (B) 2
(Ac-I-P-P-P-(R)NH-PEG12-Biotin -I-I-Indole-seco-CBI). P = N-methylpyrrole and I = N-methylimidazole.
and SKBR3 cells were plated into the 6-well plate at 4× 105
cells/well. The cells were then treated with 50 and 100 nM
of alkylating PIP 2 for 48 h with DMSO as a correspond-
ing control sample. After 48 h, total RNA was isolated us-
ing RNEasy Kit (Qiagen) and cDNA was synthesized by
ReverTra Ace qPCR RT Master mix with genomic DNA
remover (Toyobo, Japan) following the manufacturer’s in-
structions. The expression level of ERBB2 was normalized
using β-actin, as an internal control.
The primers used in this study includes, β-actin sense,
5′-CAATGTGGCCGAGGACTTTG-3′ and antisense, 5′-
CATTCTCCTTAGAGAGAAGTGG-3′. The sense primer
of ERBB2 is 5′-AGCCGCGAGCA CCCAAGT-3′ and an-
tisense, 5′-TTGGTGGGCAGGTAGGTGAGTT-3′.
RESULTS
Bind-n-Seq with PIP-indole-seco-CBI conjugate 1
High-resolution denaturing polyacrylamide gel elec-
trophoresis from our previous report showed multiple
DNA-alkylating sites for the PIP-indole-CBI conjugate (B)
(16). These results are biased toward identifying primary
DNA-alkylating sites. To address this kind of issue, we
synthesized a biotin-conjugated PIP-indole-seco-CBI
conjugate 1 (synthetic procedure is given in Supplemen-
tary Data) and examined 1 for Bind-n-Seq (Figure 1B
and C) (25,40–41) (experimental procedure is given in
the ‘Materials and Methods’ section). The method is
high-throughput sequencing-based, which may allow
unbiased primary binding motif identification. Seco-CBI is
readily converted to its cyclopropyl form CBI, and reacts
with its DNA-reactive site (42). The CBI could possibly
depurinate the DNA alkylation site during heat elution of
enriched DNA in Bind-n-Seq. Therefore, we performed a
PCR with sequencing adapter-specific primers to retrieve
the damaged strand (Figure 1C). The purified enriched
DNA was subjected to high-throughput sequencing. High
quality uniquely randomized sequence reads were analyzed
using the Bind-n-Seq analysis method (25) to obtain
the high-affinity DNA-alkylating site of 1. The DNA
showed a highly enriched ‘k-mer’ (k = 6) binding site.
The enriched motif with 24.11-fold enrichment defined the
DNA-alkylating sites of 1 and matches the PIP canonical
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Figure 2. PIP-indole-seco-CBI conjugate DNA-alkylating motifs. (A) Bind-n-Seq analysis identified high-affinity DNA-alkylating motif for 1. (B) One
possible binding in its complementary recognition sequence. (C) Bind-n-Seq analysis identified a high-affinity DNA-alkylating motif for 2.
Figure 3. Work flow for affinity purification-based high-throughput sequencing using PIP-indole-seco-CBI conjugates in the nucleus of human cells.
binding rule. A graphical representation of the identified
high-affinity motif for 1 is shown in Figure 2A; and its
corresponding highly enriched sequences are given in
Supplementary Table S1. Supplementary Table S1 also
shows the other potential binding sites of 1 at ranks 3 and
6 (highlighted in green). Although the recognition site of 1
followed the PIP canonical binding rule, the alkylation site
of 1 (sixth position from the 5′ end of the motif) was found
to be W (A or T) instead of the expected base, A, because
of the symmetrical nature of its binding. The results of the
Bind-n-Seq analysis of 1 are vital because they show that
this type of symmetrical PIP-indole-seco-CBI conjugate
has the capability to bind with both strands of DNA in a
forward-binding orientation (N-terminal to C-terminal of
PIP binding with 5′ to 3′ of DNA) as shown in Figure 2A
and B. When the binding of 1 is largely on symmetrical
sequences, the acquired motif is acceptable with respect to
the PIP-binding rule, but it is difficult to identify the precise
alkylation site of CBI in 1 because of its symmetrical
nature.
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Figure 4. Identified high-affinity DNA-alkylating motif of 2 in human ge-
nomic enriched sequence.
Bind-n-Seq with PIP-indole-seco-CBI conjugate 2
The investigation of Bind-n-Seq results for 1 showed the sig-
nificance of PIP binding to its target site, but could not elu-
cidate theCBI alkylation site. Taken together, our results for
compound 1 motivated us to inspect the exact CBI alkyla-
tion site within a PIP conjugate. Therefore, we synthesized
another asymmetrical PIP-indole-seco-CBI conjugate 2.We
designed 2 by replacing I with P in 1, to obtain asymmet-
rical binding (synthetic procedure is given in the Supple-
mentary Data). Accordingly, 2was subjected to Bind-n-Seq
analysis. Analysis of the sequence reads obtained from 2 en-
richedDNA is shown in Supplementary Table S2. The high-
affinity DNA-alkylating motif of 2 (Figure 2C) was derived
from 7.99- and 7.36-fold enrichment (corresponding highly
enriched sequences are given in Supplementary Table S2).
The motif obtained follows the binding rule and specific A
alkylation site for CBI in 2. These findings support our ear-
lier report of specific A alkylation by PIP-CBI conjugates
within its recognition sequence (43).
Bind-n-Seq with PIP-conjugate 5
To confirm the significance of the enrichedDNA-alkylating
motif of PIP-indole-seco-CBI conjugates and PCR repos-
session of the alkylated DNA strand, we performed a Bind-
n-Seq experiment (21-mer randomized region) with our
previously reported (26) biotinylated PIP-Conjugate 5 (de-
signed to target 8 bp). Bind-n-Seq data was analyzed for
the 8 and 9 bp motif windows (k = 8 and k = 9) to ob-
tain the fold enrichment based on the control experiment
(experiment without PIP-conjugate 5). High-scoring motif
hits (Supplementary Figure S2) clearly demonstrated that
there is no sequence selectivity at the ninth position of the
motif (from the 5′ end of the motif). By contrast, PIP con-
jugate 2 showed a distinct (A) adenine-specific alkylation at
the targeted sixth position from the 5′ end of the motif. This
base specific alkylation site identification could be possible
only when there is recovery of previously damaged alkylated
DNA. These results demonstrated that successful retrieval
of a damaged DNA strand could be possible using PCR re-
action.
Identification of PIP-indole-seco-CBI conjugate 2 high affin-
ity DNA-alkylating site in chromatinized human genome
We then sought to extend the high-throughput sequencing
approach to examine how chromatinized genomic architec-
ture can impact the binding of 2 across the human genome
in nuclei isolated from live cells. Consistent with this ap-
proach, we developed a method (Figure 3) based on the
COSMIC approach (22) that includes affinity purification-
based high-throughput sequencing of human genomic re-
gions enriched with 2 without any photo-crosslinking pro-
cedure. We employed this method to elucidate the bind-
ing preferences of 2 in the biologically dynamic, histone-
packed chromatinized surroundings of the nuclei (experi-
mental procedure is described in the ‘Materials and Meth-
ods’ section). The qualified sequencing libraries were sub-
jected to sequencing. The processed sequence data was
mapped along the human genome. To comprehensively de-
termine the DNA-alkylating site (primary motif), we per-
formed motif detection using a Bind-n-Seq data analysis
pipeline. Among the enriched sequences (normalized with
the control experimental data), the high-scoring motif hit
(rank 1 in Supplementary Table S3) was unique DNA-
alkylation site of 2 (Figure 4) (enriched sequence details
are given in Supplementary Table S3). Interestingly, the
identified primary motifs of 2 propose that its sequence-
specific DNA-alkylation of base A remains highly similar
in both complex chromatinized human genomic DNA and
randomized oligomer-based Bind-n-Seq analyses.
To compare the sensitivity of 2 enrichment, we have con-
ducted MACS peak calling and the cross-correlation of
identified DNA-alkylating motif with the obtained post-
filtered genomic sequence data (25–30 million). Then we
plotted (Figure 5B) the identified motif (5′-AGGTCA-3′)
on the genome-wide enriched peaks with the window of 300
bp (–150 to 150 bp from the center (0) of the peak). This
showed the greatest precision of distribution frequency with
a 2 predicted recognition site (5′-WGGWCA-3′). Whereas,
1 bp mismatch (5′-AGGTWA-3′) and 2 bp mismatch (5′-
AGGCWA-3′) sequence of 2 showed poor distribution in
the enriched regions. In Figure 5B, we have also illustrated
the mismatch DNA-alkylating site (5′-AGGTCT-3′) that
displayed very low frequency. These results confirm the ef-
ficiency of the genomic pull-down enrichment by 2. Ad-
ditionally, the  -turn in 2 uniquely recognized the base A
(adenine), which may be the result of chromatinized DNA
binding (Figure 4). This exclusive detection was further ver-
ified with the results of poorly dispersed possible recogni-
tion of T (5′-TGGTCA-3′) by the  -turn in the conjugate 2
(green line in Figure 5B). Reproducibility of the experiment
is confirmed with R2 = 0.92 for two separate experimen-
tal enriched motifs (Supplementary Figure S1) and MACS
peak annotation distribution (Supplementary Table S4).
Identification of PIP-indole-seco-CBI conjugate 2 represen-
tative enriched sites in chromatinized human genome
Targeted gene silencing can be achieved by PIPs, either by
designing the PIPs to the transcription factor recognition
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Figure 5. Genomic enrichment and DNA-alkylating site distribution of PIP-indole-seco-CBI conjugate 2: (A) (i) Predicted binding sites based on the
canonical binding rule, (ii) experimentally identified high-affinity DNA-alkylating motif in human genome, (iii) affinity purification based sequencing
enriched regions containing experimentally identified high-affinity DNA-alkylating motif. (B) 2 related possible binding sites (predicted, experimentally
identified, possible recognition of T by the  -turn in the conjugate, 1 bp mismatch, 2 bp mismatch and alkylation site mismatch) genome-wide distribution
frequencies in the peak enriched region with the MACS peak window of 300 bp (−150 to 150 bp from the center (0) of the enriched peak). (C) 2 enriched
region distribution on broad classes of chromatin states (six classes of chromatin states such as promoter (active, weak and poised), enhancer (strong and
weak), insulator, transcribed (strongly (Txn transition and Txn elongation) and weakly transcribed regions), repressed and inactive states (heterochro-
matin)) (chromatin stated were organized based on the ENCODE-ChromHMMdata). (D) Nucleosomal occupancy of the genome-wide 2 enriched region
containing identified binding site. The region inside the yellow box corresponding to the nucleosomal region of ∼147 bps (nucleosomal positioning was
measured based on the ENCODE nucleosomal positioning data).
site on the gene promoter (44) or by alkylating PIPs targeted
to the coding region of the respective gene producing non-
functional truncated mRNA (45). To obtain deeper insight
into the gene of interest targeted by PIP-indole-seco-CBI
conjugate 2, the enriched peak regions were mapped and
correlated with the DNA-alkylating site of 2 on the human
genome. One of the significantly enriched genomic regions
ERBB2 is shown in Figure 6 (enrichment details are given
in Supplementary Table S5) with the DNA-alkylating site.
Several oncogenes have been studied in human cancers, but
only a few have been reported to play a critical role in the
progression of breast cancer. ERBB2 is one such oncogene
overexpressed in many epithelial cancers and in about 20%
of early-stage breast cancer patients with low survival rates,
and confers chemo-resistance (46). By contrast, the univer-
sally expressed reference genes, such asACTB andGAPDH
did not show any enriched regions (Supplementary Figure
S5). However, the quantification of ERBB2 mRNA (us-
ing real-time PCR) in conjugate 2 treated human BJ skin
fibroblast cells and SKBR3 breast adenocarcinoma cells
showed inhibition of ERBB2 mRNA expression with re-
spect to reference genes in both cell types (Supplementary
Figure S6).
Genome-wide analysis of PIP-indole-seco-CBI conjugate 2
enriched sites distribution
To analyze the influence of complex eukaryotic chromatin
conformation on the DNA-alkylation preferences of PIP
conjugate, we performed a computational genome-wide dis-
tribution survey of 2 binding sites (predicted binding site 5′-
WGGWCA-3′ based on the binding rule and genome-wide
experimentally derived binding site 5′-AGGTCA-3′) in var-
ious annotated regions of the human genome (Supplemen-
tary Table S6 and Figure 5A i and ii). The total numbers
of experimentally identified binding sites are significantly
less than the predicted binding sites. This clearly shows that
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Figure 6. Genome-wide mapping of PIP-indole-seco-CBI (2) (A) Two binding and enriched genomic area in the ERBB2 gene coding region. (B) Two
binding and enriched genomic area of the ERBB2 promoter region.
chromatin conformation plays a critical role in polyamide
binding. We have also annotated the 2 enriched genomic re-
gions across the human genome (Supplementary Table S6
and Figure 5A iii). The result showed high correlation with
the genome-wide distribution pattern of DNA-alkylating
sites.
We next sought to assess the annotated position of the
predominant 2 enriched regions across the genome.We first
compared the distribution of 2 identified motifs (DNA-
alkylating site) with predicted binding sites (Supplementary
Table S7 and Figure S3a) that retained comparable distri-
bution of genomic positions (3′-UTR, miRNA, ncRNA,
TTS, pseudo genes, exon, intron, intergenic, promoter and
5′-UTR). We again compared 2 enriched regions with iden-
tified and predicted binding regions that showed the rate of
enrichment to be high in TTS, intron, intergenic and pro-
moter regions when compared with the other genomic re-
gions (Supplementary Table S7 and Figure S3b and c). To
test this predominance, we generated an aggregation plot
(37) with 2 enriched reads (Supplementary Figure S4). The
average enrichment read density in the upstream (–4 kb)
of TSSs (proximal and distal promoter) possess convincing
read density and gene body detects crimped average enrich-
ment read density because of the existence of 5′-UTR, 3′-
UTR, coding exons and introns in the gene body (Supple-
mentary Figure S4). These distribution marks are consis-
tent with the enrichment distribution we determined earlier.
We next asked whether 2 enrichment profiling with var-
ious chromatin states could be used to infer a systematic
means of perceiving PIP accessible regions; because the
chromatin framework of a genome plays a central role in
controlling DNA access. We examined the 2 enriched sites
distribution on ChromHMM segments (47) and we present
in Figure 5C, on a broad scale; (i) 2 differs in accessing vari-
ous promoter states and its low average enrichment density
on active promoters may support the target specific gene
suppression by PIP conjugates. (ii) The positional distribu-
tion along enhancer, insulator and transcribed regions con-
tain an almost equivalent form of enrichment, so designing
PIPs to target such genomic positions may provide a correl-
ative genome-wide effect. (iii) 2 showed characteristic pat-
terns of chromatin accessibility that have been observed at
repressed and inactive states. By contrast, the access of nu-
cleosomal DNA by PIP is limited (20). In line with this, we
sought to inspect 2 enrichment sites on nucleosomes at a
fine scale of an approximately 147 bps window, we investi-
gated the positioning of nucleosomes with the enriched re-
gions using theMNase-Seq data (33). In thismodel, wewere
able to estimate the 2 binding density, which appears to be
higher at the ends of nucleosome than in the core middle
region (Figure 5D). Our data with greater precision at the
genomic scale confirm the previously reported (studied at
the defined nucleosomal core particle context) limitation of
PIP accessibility; in addition, we report that this limitation
might be as a result of the central core of well-positioned
nucleosomes. Overall, our genome-wide enrichment assess-
ment results provide a deeper understanding of the PIP ac-
cessibility toward chromatinized DNA.
DISCUSSION
New methods in chemical biology with deep sequencing
applications and data analysis are constantly being de-
veloped (24). In this study, we have made use of high-
throughput sequencing technology to show the significant
sequence-specific DNA-alkylation of PIP-indole-seco-CBI
conjugates corresponding to the proposed DNA-binding
rule. The binding specificity of our small molecule remains
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similar in a broad sequence context of free DNA and
in complex chromatinized human genome. However, our
DNA-alkylating site mapping on the nucleosome resulting
in this sequence-specific binding have limitations on the cen-
tral core of chromatinized DNA. Progress in the field of se-
quencing technologies has allowed us to conduct this study
cost-efficiently, and it may be a useful method for other
DNA-binding small molecule design and redesign in the
context of the complex genome space. Our results also in-
dicate that the structural composition of PIP-indole-seco-
CBI conjugates favorably alters the sequence specificity of
PIPs. In future, this method may be an efficient tool for
studying sequence-specific alkylation and in designing small
molecules for targeted gene silencing compared with con-
ventional polyacrylamide gel electrophoresis analysis.
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